Intensification of seasonal extremes given a 2°C global warming target

A CROSS-MODEL COMPARISON OF GLOBAL LONG-

A CROSS-MODEL COMPARISON OF GLOBAL LONG-TERM TECHNOLOGY DIFFUSION UNDER A 2°C CLIMATE CHANGE CONTROL TARGET

✍ VAN DER ZWAAN, B. C. C.; RÖSLER, H.; KOBER, T.; ABOUMAHBOUB, T.; CALVIN, K. V.; 📂 Article 📅 2013 🏛 World Scientific 🌐 English ⚖ 778 KB

Global microRNA expression profiles in i

Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes

✍ B. M. Herrera; H. E. Lockstone; J. M. Taylor; M. Ria; A. Barrett; S. Collins; P. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 314 KB

Impact of freshwater on a subarctic coas

Impact of freshwater on a subarctic coastal ecosystem under seasonal sea ice (southeastern Hudson Bay, Canada). I. Interannual variability and predicted global warming influence on river plume dynamics and sea ice

✍ R.G. Ingram; J. Wang; C. Lin; L. Legendre; L. Fortier 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 938 KB

Efficacy and safety of a fixed-ratio com

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

✍ Gough, Stephen C L; Bode, Bruce; Woo, Vincent; Rodbard, Helena W; Linjawi, Sulta 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 284 KB

Efficacy and safety of a fixed-ratio com

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

✍ Gough, Stephen C L; Bode, Bruce; Woo, Vincent; Rodbard, Helena W; Linjawi, Sulta 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 284 KB

## Background: A fixed-ratio combination of the basal insulin analogue insulin degludec and the glucagon-like peptide-1 (glp-1) analogue liraglutide has been developed as a once-daily injection for the treatment of type 2 diabetes. we aimed to compare combined insulin degludec-liraglutide (ideglira

The Efficacy and Safety of Insulin Deglu

The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes

✍ Meneghini, L.; Atkin, S. L.; Gough, S. C. L.; Raz, I.; Blonde, L.; Shestakova, M 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 842 KB